The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis
Creators
- Begg, A.C.1
- Haustermans, K.1
- Hart, A.A.M.2
- Dische, S.3
- Saunders, M.3
- Zackrisson, B.4
- Gustaffson, H.4
- Coucke, P.5
- Paschoud, N.5
- Hoyer, M.6
- Overgaard, J.6
- Antognoni, P.7
- Richetti, A.7
- Bourhis, J.8
- Bartelink, H.1
- Horiot, J.-C.9
- Corvo, R.10
- Giaretti, W.10
- Awwad, H.11
- Shouman, T.11
- Jouffroy, T.12
- Maciorowski, Z.13
- Dobrowsky, W.14
- Struikmans, H.15
- Rutgers, D.15
- Wilson, G.D.16
- 1. Division of Experimental Therapy, Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam (Netherlands)
- 2. Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam (Netherlands)
- 3. Marie Curie Research Wing for Oncology, Mount Vernon Centre for Cancer Treatment, Rickmansworth Road, Northwood Middlesex (United Kingdom)
- 4. Department of Oncology, Umea University, S901 85 Umea (Sweden)
- 5. Department of Radiation Oncology, Centre Hospitalier Univ. Vaudois, CH1101 Lausanne (Switzerland)
- 6. The Danish Cancer Society, Department of Clinical Oncology, Institute of Cancer Research Radium Stationen, Norrebrogade 44, DK8000 AarhusC (Denmark)
- 7. Divisione di Radioterapia, Ospedale di Circolo, L. Borri 57, 21100 Varese (Italy)
- 8. Department of Radiotherapy, Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif Cedex (France)
- 9. Service de Radiotherapie, Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Rue du Professeur Marion, 21034 DIJON Cedex (France)
- 10. Department of Radiotherapy, National Institute for Cancer Research, V.le Benedetto XV, 10, 16132 Genoa (Italy)
- 11. Department of Radiotherapy, National Cancer Institute, Kasr El Aini Street, Fom El Khalig Cairo (Egypt)
- 12. Departments of Surgery and of Oncology/Radiotherapy, Institut Curie, 26 rue d'Ulm, 75248 Paris Cedex (France)
- 13. Cytopathologie, Institut Curie, 26 rue D'Ulm, 75248 Paris Cedex (France)
- 14. Department of Radiotherapy and Radiobiology, Algemeines Krankenhaus der Stadt Wien, Waeringer Guertel 18-20, A-1090 Vienna (Austria)
- 15. Afdeling Radiotherapie, AZU, Heidelberglaan 100, 3584 CX Utrecht (Netherlands)
- 16. Gray Laboratory Research Trust, PO Box 100, Mount Vernon Hospital, Northwood Middlesex (United Kingdom)
Description
Purpose: The aim of this study was to assess the potential of pre-treatment cell kinetic parameters to predict outcome in head and neck cancer patients treated by conventional radiotherapy.Materials and methods: Data from 11 different centers were pooled. Inclusion criteria were such that the patients received radiotherapy alone, and that the radiotherapy was given in an overall time of at least 6 weeks with a dose of at least 60 Gy. All patients received a tracer dose of either iododeoxyuridine (IdUrd) or bromodeoxyuridine (BrdUrd) intravenously prior to treatment and a tumor biopsy was taken several hours later. The cell kinetic parameters labeling index (LI), DNA synthesis time (Ts) and potential doubling time (Tpot) were subsequently calculated from flow cytometry data, obtained on the biopsies using antibodies against I/BrdUrd incorporated into DNA. Each center carried out their own flow cytometry analysis.Results: From the 11 centers, a total of 476 patients conforming to the inclusion criteria were analyzed. Median values for overall time and total dose were 49 days and 69 Gy, respectively. Fifty one percent of patients had local recurrences and 53% patients had died, the majority from their disease. Median follow-up was 20 months; being 30 months for surviving patients. Multivariate analysis revealed that T-stage, maximum tumor diameter, differentiation grade, N-stage, tumor localization and overall time correlated with locoregional control, in decreasing order of significance. For the cell kinetic parameters, univariate analysis showed that only LI was significantly associated with local control (P=0.02), with higher values correlating with a worse outcome. Ts showed some evidence that patients with longer values did worse, but this was not significant (P=0.06). Tpot showed no trend (P=0.8). When assessing survival in a univariate analysis, neither LI nor Tpot associated with outcome (P=0.4, 0.4, respectively). Surprisingly, Ts did correlate with survival, with longer values being worse (P=0.02). In the multivariate analysis of local control, LI lost its significance (P=0.16).Conclusions: The only pretreatment kinetic parameter for which some evidence was found for an association with local control (the best end-point for testing the present hypothesis) was LI, not Tpot, and this evidence disappeared in a multivariate analysis. It therefore appears that pretreatment cell kinetic measurements carried out using flow cytometry, only provide a relatively weak predictor of outcome after radiotherapy in head and neck cancer. (Copyright (c) 1999 Elsevier Science B.V., Amsterdam. All rights reserved.)
Additional details
Publishing Information
- Journal Title
- Radiotherapy and Oncology
- Journal Volume
- 50
- Journal Issue
- 1
- Journal Page Range
- p. 13-23
- ISSN
- 0167-8140
- CODEN
- RAONDT
INIS
- Country of Publication
- Ireland
- Country of Input or Organization
- Austria
- INIS RN
- 31063954
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANIMAL CELLS; FORECASTING; HEAD; KINETICS; MULTIVARIATE ANALYSIS; NECK; NEOPLASMS; RADIOTHERAPY
- Descriptors DEC
- BODY; DISEASES; MATHEMATICS; MEDICINE; NUCLEAR MEDICINE; RADIOLOGY; STATISTICS; THERAPY